Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Eosinophilic Esophagitis

• A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)
• A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis
• A Phase 2 Study of Barzolvolimab in Patients With Eosinophilic Esophagitis
• A Study to Investigate Safety and Tolerability of NDX-3315 in Healthy Participants and Patients With Eosinophilic Esophagitis
• 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-3)
• A Trial Evaluating EP-104IAR in Adults With Eosinophilic Esophagitis
• Mesalazine Oral Suspension in Active Eosinophilic Esophagitis
• SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects
• Zemaira Eosinophilic Esophagitis Pilot Study
• Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)
• Examining the Effect of Ondansetron on Bowel Prep Success
• Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis
• A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
• Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE)
• A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab
• A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis
• A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis
• Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial
• Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis
• A Study to Investigate the Efficacy and Tolerability of ESO-101 in Patients With Eosinophilic Esophagitis
• Safety and Pharmacokinetics of Orodispersible BT-11 in Active Eosinophilic Esophagitis
• A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
• A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
• An Extension Study of Lirentelimab in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
• Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
• A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis
• A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)
• Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
• Antihistamines in Eosinophilic Esophagitis
• Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)
• Radiation Dose in Humans From Orally Administered Tc99m-Heparin
• EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone
• Dupilumab in Eosinophilic Gastritis
• An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
• Mepo for EoE Study
• Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
• A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
• Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
• Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)
• Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
• An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
• Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis
• SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
• An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
• Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids
• A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
• Milk Patch for Eosinophilic Esophagitis
• Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis
• Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis
• Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE)
• Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
• The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
• Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis
• Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.
• Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
• Bethanechol for Eosinophilic Esophagitis
• Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies
• Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
• Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis
• Eosinophilic Esophagitis Clinical Therapy Comparison Trial
• Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
• Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
• Eosinophilic Esophagitis Treatment: Montelukast vs Fluticasone
• OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
• New Serological Markers for Eosinophilic Esophagitis
• A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021
• Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
• A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children
• The Frequency of Eosinophilic Esophagitis in Patients With Heartburn That is Refractory to Proton Pump Inhibitors
• Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis
• Proof of Concept Study of OC000459 in Eosinophilic Esophagitis
• Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
• A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis
• Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
• Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis
• Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
• Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis
• The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
• Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis
• Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
• Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis
• Trial of Montelukast in Eosinophilic Esophagitis
• A Study of Flovent in Patients With Eosinophilic Esophagitis
• Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
• Topical Steroid Treatment for Eosinophilic Esophagitis
• An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients
• Budesonide for Eosinophilic Esophagitis
• A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
• Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
• Montelukast in the Treatment of Duodenal Eosinophilia
• Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis
• A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
• Omalizumab to Treat Eosinophilic Gastroenteritis